These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7523237)

  • 41. Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
    Xie J; Cao J; Wang JF; Zhang BH; Zeng XH; Zheng H; Zhang Y; Cai L; Wu YD; Yao Q; Zhao XC; Mao WD; Jiang AM; Chen SS; Yang SE; Wang SS; Wang JH; Pan YY; Ren BY; Chen YJ; Ouyang LZ; Lei KJ; Gao JH; Huang WH; Huang Z; Shou T; He YL; Cheng J; Sun Y; Li WM; Cui SD; Wang X; Rao ZG; Ma H; Liu W; Wu XY; Shen WX; Cao FL; Xiao ZM; Wu B; Tian SY; Meng D; Shen P; Wang BY; Wang Z; Zhang J; Wang L; Hu XC
    Breast Cancer Res Treat; 2018 Apr; 168(2):389-399. PubMed ID: 29230663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Application of pegylated recombinant human granulocyte colony-stimulating factor to prevent chemotherapy-induced neutropenia in patients with lymphoma: a prospective, multicenter, open-label clinical trial].
    Huang HQ; Bai B; Gao YH; Zou DH; Zou SH; Tan H; Song YP; Li ZY; Jin J; Li W; Su H; Gong YP; Zhong MZ; Shuang YR; Zhu J; Zhang JQ; Cai Z; Teng QL; Sun WJ; Yang Y; Xia ZJ; Chen HL; Hua LM; Bao YY; Wu N
    Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):825-830. PubMed ID: 29166732
    [No Abstract]   [Full Text] [Related]  

  • 44. [Promotive effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on recovery from neutropenia induced by fractionated irradiation in mice].
    Kabaya K; Watanabe M; Kusaka M; Seki M; Fushiki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Aug; 54(9):908-16. PubMed ID: 7524017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia.
    Wu FP; Wang J; Wang H; Li N; Guo Y; Cheng YJ; Liu Q; Yang XR
    Exp Ther Med; 2015 Mar; 9(3):761-765. PubMed ID: 25667625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant canine granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in dogs.
    Yamamoto A; Fujino M; Tsuchiya T; Iwata A
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):271-5. PubMed ID: 21645930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor.
    Okamura J; Yokoyama M; Tsukimoto I; Komiyama A; Sakurai M; Imashuku S; Miyazaki S; Ueda K; Hanawa Y; Takaku F
    Pediatr Hematol Oncol; 1992; 9(3):199-207. PubMed ID: 1381941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma.
    Yoshida T; Nakamura S; Ohtake S; Okafuji K; Kobayashi K; Kondo K; Kanno M; Matano S; Matsuda T; Kanai M
    Cancer; 1990 Nov; 66(9):1904-9. PubMed ID: 1699654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC).
    Zhou C; Huang Y; Wang D; An C; Zhou F; Li Y; Chen G; Wu C; He J; Wu G; Song X; Gao J; Liu W; Li B; Shi J; Huang C; Yu J; Feng J; Yue H; Shi M; Xia J
    Clin Lung Cancer; 2016 Mar; 17(2):119-27. PubMed ID: 26781346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic activity (leukopoietic effect) of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after rectal administration in rabbits with leukopenia induced by cyclophosphamide.
    Watanabe Y; Kiriyama M; Oe J; Kikuchi R; Mizufune Y; Matsumoto M
    Biol Pharm Bull; 1996 Aug; 19(8):1064-7. PubMed ID: 8874817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
    Rotondaro L; De Paolis E; Ferrero D; D'Alatri L; Raucci G; Fabbri A; Gerwig GJ; Kamerling JP; Mariani MF; Mele A; De Santis R
    Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y; Okabe M; Kurosawa M; Maekawa I; Higuchi M; Kawamura M; Morioka M; Suzuki S; Ohmura T; Fujimoto N
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of recombinant human granulocyte colony-stimulating factor on granulopoiesis in mice recovering from cyclophosphamide treatment.
    Barrios L; Poletti OH; Agustini MI
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):275-80. PubMed ID: 11031727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on rhG-CSF modified with polyethylene glycol].
    Zhang LL; Zheng CY; Lei JD; Ma GH; Su ZG; Wang L
    Sheng Wu Gong Cheng Xue Bao; 2005 Nov; 21(6):965-9. PubMed ID: 16468354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia.
    Hirashima K; Yoshida Y; Asano S; Takaku F; Omine M; Furusawa S; Abe T; Abe T; Dohy H; Tajiri M
    Biotherapy; 1991; 3(4):297-307. PubMed ID: 1723891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities.
    Tiwari D; Haque S; Jawed A; Mishra MK; Govender T; Kruger HG
    Protein Pept Lett; 2015; 22(10):877-84. PubMed ID: 26216266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
    Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].
    Liu KQ; Wang Y; Zhao Z; Lin D; Zhou CL; Liu BC; Gong XY; Zhao XL; Wei SN; Zhang GJ; Gong BF; Li Y; Liu YT; Mi YC; Wang JX; Wei H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):497-501. PubMed ID: 31340623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.